ALLIANCEBERNSTEIN L.P. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 40 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$50,000
-20.6%
37,300
-33.3%
0.00%
Q4 2018$63,000
-59.1%
55,9000.0%0.00%
Q3 2018$154,000
-23.0%
55,9000.0%0.00%
Q2 2018$200,000
+19.0%
55,900
+2.4%
0.00%
Q1 2018$168,000
-51.2%
54,6000.0%0.00%
Q4 2017$344,000
-7.8%
54,6000.0%0.00%
Q3 2017$373,000
-11.6%
54,600
-7.8%
0.00%
Q2 2017$422,000
-17.1%
59,200
+6.9%
0.00%
Q1 2017$509,000
+128.3%
55,4000.0%0.00%
Q4 2016$223,000
+5.2%
55,4000.0%0.00%
Q3 2016$212,000
-10.9%
55,4000.0%0.00%
Q2 2016$238,000
+11.7%
55,400
+20.3%
0.00%
Q1 2016$213,000
-57.7%
46,040
-8.2%
0.00%
Q4 2015$503,000
+27.0%
50,140
-5.6%
0.00%
Q3 2015$396,000
-99.2%
53,140
-95.0%
0.00%
-100.0%
Q2 2015$50,248,000
+30.8%
1,059,196
+1.0%
0.04%
+35.5%
Q1 2015$38,414,000
-6.4%
1,048,429
+1.4%
0.03%
-8.8%
Q4 2014$41,055,000
+146525.0%
1,033,880
+73748.6%
0.03%
Q3 2014$28,000
-26.3%
1,400
-50.0%
0.00%
Q2 2014$38,000
+1800.0%
2,800
+1791.9%
0.00%
Q1 2014$2,0000.0%1480.0%0.00%
Q4 2013$2,000
-66.7%
148
-73.0%
0.00%
Q3 2013$6,000
+20.0%
548
-24.1%
0.00%
Q2 2013$5,0007220.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2013
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders